Financial News

Rattled investors send markets plummeting

Talks in Washington D.C. of impeachment and obstruction of justice rattled investors to send the markets plummeting to a sharply lower close with the Dow crashing 372 points to 20,606. Nasdaq collapsed 158 points to 6,011.


On the upside


Syndax Pharmaceuticals (Nasdaq: SNDX) announced that patients in the ENCORE 601 non-small cell lung cancer trial will advance to the second stage of the Phase 2 trial.


Pulmatrix (Nasdaq: PULM) chief financial officer Bill Duke said that the company's PUR1900 inhaled therapy for treating fungal infections has the potential to be a blockbuster.


The Patent Trial and Appeal Board ruled in favor of Coherus BioSciences' (Nasdaq: CHRS) petitions for Inter Partes Review of AbbVie's U.S. Patent 8,889,135.


On the downside


Bebe (Nasdaq: BEBE) will have to make between $60 to $65 million in lease termination payments.


Roth Capital downgraded Plug Power (Nasdaq: PLUG) from a Neutral rating to a Sell rating and cut its price target from $2.25 to $1.30.

Shares of Forterra (Nasdaq: FRTA) fell for the fourth day.


The broader S&P 500 skidded 43 points to 2,357. Bitcoin surged $77 to $1770.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback